Patents Assigned to NIDO BIOSCIENCES, INC.
  • Crystalline forms of 3-(5-(2-hydroxy-2-methylpropoxy)-6-methylpyrazin-2-yl)-1H-indole-7-carbonitrile
    Patent number: 12168650
    Abstract: This disclosure provides crystalline forms of an androgen receptor modulator, and methods of making and using these forms.
    Type: Grant
    Filed: January 13, 2023
    Date of Patent: December 17, 2024
    Assignee: NIDO BIOSCIENCES, INC.
    Inventors: Bakary-Barry Toure, Magnus Ronn
  • Bicyclic compounds as androgen receptor modulators
    Patent number: 12012398
    Abstract: Provided herein are compounds that bind to BF3 of an androgen receptor (AR), which can modulate the AR for the treatment of Kennedy's disease.
    Type: Grant
    Filed: July 11, 2022
    Date of Patent: June 18, 2024
    Assignee: NIDO BIOSCIENCES, INC.
    Inventors: Bakary-Barry Toure, Mark Andrew Gallop
  • Indole compounds as androgen receptor modulators
    Patent number: 11667624
    Abstract: Provided herein are indole compounds that bind to BF3 of an androgen receptor (AR), which can modulate the AR for the treatment of Kennedy's disease.
    Type: Grant
    Filed: July 20, 2021
    Date of Patent: June 6, 2023
    Assignee: NIDO BIOSCIENCES, INC.
    Inventors: Bakary-Barry Toure, Mark Andrew Gallop, Paul Andrew Barsanti